Taken together, our novel selective HDAC6 inhibitor 25253 demonstrated a synergic effect when combined with Taxol not only in ARID1A-null TOV21G cells but also in ARID1A wild-type ES-2 ovarian cancer cells. Here, HDAC6 is linked to ovarian carcinoma.